CLINICAL_TRIALS
trial_result
· 2023-08-04
Clinical Trial Update: A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas [Phase 2]
Summary
Phase 2 clinical trial update for SB939 in translocation-associated recurrent/metastatic sarcomas has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NCIC Clinical Trials Group | Conditions: Metastatic Sarcoma | Phase 2 | Status: COMPLETED